NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Rosetta Stone Inc. (NYSE - RST), Principia Biopharma Inc. (Nasdaq - PRNB), BMC Stock Holdings, Inc. (Nasdaq - BMCH)
BALA CYNWYD, PA / ACCESSWIRE / September 8, 2020 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590. There is no cost or financial obligation to you.
Rosetta Stone Inc. (NYSE:RST)
Under the terms of the agreement, Rosetta Stone shareholders will only receive $30.00 for each share of Rosetta Stone they own. The investigation concerns whether the Rosetta Stone Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Cambium is paying too little for the Company.
Additional information can be found at http://www.brodskysmith.com/cases/rosetta-stone-inc-nyse-rst/, or call 877-534-2590. No cost or obligation to you.
Principia Biopharma Inc. (Nasdaq:PRNB)
Under the terms of the agreement, the Company's shareholders will receive only $100 per share in cash for each share of Principia they own. The investigation concerns whether the Principia Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Sanofi is underpaying for the Company. For example, at least one analyst following the Company has set a price target of $112.00 a share.
Additional information can be found at http://www.brodskysmith.com/cases/principia-biopharma-inc-nasdaq-prnb/, or call 877-534-2590. No cost or obligation to you.
BMC Stock Holdings, Inc. (Nasdaq:BMCH)
Under the terms of the agreement, BMCH shareholders will receive only 1.3125 shares of Builders FirstSource for each share of BMCH they own, an implied per-share consideration of $36.63 based upon Builders FirstSource's closing price of $27.91 on August 26, 2020. The investigation concerns whether the BMCH Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Builders FirstSource is paying too little for the Company. For example, at least one wall street analyst following the Company has set a target price of $49.00 per share for BMCH.
Additional information can be found at http://www.brodskysmith.com/cases/bmc-stock-holdings-inc-nasdaq-bmch/, or call 877-534-2590. No cost or obligation to you.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE: Brodsky & Smith, LLC
View source version on accesswire.com:
https://www.accesswire.com/605186/NOTICE--IMPORTANT-SHAREHOLDER-INVESTIGATION-UPDATE-Brodsky-Smith-LLC-Reminds-Investors-of-Investigations-Related-to-the-Following-Companies-Rosetta-Stone-Inc-NYSE--RST-Principia-Biopharma-Inc-Nasdaq--PRNB-BMC-Stock-Holdings-Inc-Nasdaq
